MetaCap

Actuate Therapeutics Statistics

NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.2253+0.0115 (+5.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Actuate Therapeutics by the numbers

Actuate Therapeutics has a market capitalization of $13.6 million based on 60.38M shares outstanding. With trailing EPS of $-0.76, Actuate Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 60.0% below its 50-day average and 87.4% below its 200-day average.

Average daily trading volume is 807.24K shares, or about $181,872 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ACTU valuation vs. peer median

ACTU compared with the median of 8 peer companies
MetricACTUPeer medianDifference
Market cap$13.60M$13.01M+5%
Avg. volume807.24K183.84K+339%

Peer median across 8 companies: BYSI, CTXR, TVRD, BOLT, NEUP, MCRB, ALLR, NCEL.

Valuation

Price and trading

Previous close
0.2138
Open
0.20
Day range
0.20 – 0.2475
52-week range
0.174 – 7.90
52-week change
-96.43%
Beta
—
Volume
629.80K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
13.60M
Forward Pe
-0.58
Eps
-0.76
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.90
Week52 Low
0.17
Avg Volume
807.24K
Shares Outstanding
60.38M
Ma50
0.56
Ma200
1.79
Earnings Date
Nov 13, 2026
Pct From52w High
-97.15%
Pct From52w Low
29.48%

Related